Comparison of the Efficacy of Ultrasound-guided Supra-inguinal Fascia Iliaca and Lumbar Erector Spina Plan Block in Hip Fractures

NCT07639762 | Completed

• 1 other identifier: Ivstrh
• Study Type: observational
• Target: 84
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of our study was to evaluate the efficacy and patient satisfaction level of SI-FIB and lumbar ESPB for positioning and postoperative analgesia during spinal anesthesia in patients undergoing hip fracture surgery.

Conditions

Hip Fracture; Pain Management; Multimodal Analgesia; Peripheral Nerve Block; Lumbar Erector Spinae Plane Block; Suprainguinal Fasia Iliaca Block

Keywords

Hip fracture; pain management; multimodal analgesia; suprainguinal fasia iliaca block; lumbar erector spinae plane block

Outcome Measures

Primary Outcomes (1)

• Assessment of pain during spinal anesthesia position

  The primary objective of our study is to compare the effectiveness of SI-FIB and lumbar ESPB in patients undergoing hip fracture surgery by evaluating NRS scores during positioning for spinal anesthesia.

  The NRS score will be recorded before the block. The NRS score will be recorded 20 minutes after the block is administered. The NRS score will be recorded when the patient is placed in a sitting position for spinal anesthesia.

Secondary Outcomes (3)

• Postoperative Pain Intensity at Rest and During Activity

  0, 2, 6, 12, and 24 hours postoperatively

• Additional Analgesic Consumption

  From the end of surgery to 24 hours postoperatively

• Patient Satisfaction With Postoperative Analgesia

  24 hours postoperatively

Other Outcomes (3)

• Postoperative Complications

  From the end of surgery to 48 hours

• Time to First Mobilization

  Perioperative/Periprocedural

• Length of Hospital Stay

  Perioperative/Periprocedural

Study Arms (3)

Grup-S

Patients were divided into 3 groups and grouped as Group-S with suprainguinal fascia iliaca block, Group-L with lumbar erector spina plan block and Group-C as control group. For postoperative analgesia, preoperative midazolam premedication and USG-guided suprainguinal fascia iliaca plan block with 20 ml of 0.25% Bupivacaine was planned to be performed in Group-S and lumbar erector spina plan block was planned to be performed at the L3-4 level in Group-L.

Grup-L

Patients were divided into 3 groups and grouped as Group-S with suprainguinal fascia iliaca block, Group-L with lumbar erector spina plan block and Group-C as control group. For postoperative analgesia, preoperative midazolam premedication and USG-guided suprainguinal fascia iliaca plan block with 20 ml of 0.25% Bupivacaine was planned to be performed in Group-S and lumbar erector spina plan block was planned to be performed at the L3-4 level in Group-L.

Grup-C

Patients were divided into 3 groups and grouped as Group-S with suprainguinal fascia iliaca block, Group-L with lumbar erector spina plan block and Group-C as control group. For postoperative analgesia, preoperative midazolam premedication and USG-guided suprainguinal fascia iliaca plan block with 20 ml of 0.25% Bupivacaine was planned to be performed in Group-S and lumbar erector spina plan block was planned to be performed at the L3-4 level in Group-L.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients who underwent surgery with spinal anesthesia due to hip fracture at Sancaktepe Şehit Prof. Dr. İlhan Varank Education and Research Hospital of Health Sciences University and were treated with suprainguinal plane block and lumbar rectus fascia plane block for postoperative analgesia will be examined in the study, along with patients who did not receive the block.

You may qualify if:

• years of age or older
• American Society of Anesthesiologists (ASA) I-III risk class,
• Patients and/or guardians informed and given informed consent regarding the study

You may not qualify if:

• Central-autonomic nervous system or neuropsychiatric disorders,
• Opioid use,
• Contraindications for the planned block,
• Known allergies to the medications to be administered,
• Patients who refuse to participate in the study

Sponsors & Collaborators

• Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital: lead

Study Sites (1)

Şehit Prof. Dr. İlhan Varank Sancaktepe Training and Research Hospital

Istanbul, Sancaktepe, 34785, Turkey (Türkiye)

Location

Related Publications (4)

• Hebbard P, Ivanusic J, Sha S. Ultrasound-guided supra-inguinal fascia iliaca block: a cadaveric evaluation of a novel approach. Anaesthesia. 2011 Apr;66(4):300-5. doi: 10.1111/j.1365-2044.2011.06628.x. Epub 2011 Feb 24.

  PMID: 21401544 BACKGROUND

• Desmet M, Vermeylen K, Van Herreweghe I, Carlier L, Soetens F, Lambrecht S, Croes K, Pottel H, Van de Velde M. A Longitudinal Supra-Inguinal Fascia Iliaca Compartment Block Reduces Morphine Consumption After Total Hip Arthroplasty. Reg Anesth Pain Med. 2017 May/Jun;42(3):327-333. doi: 10.1097/AAP.0000000000000543.

  PMID: 28059869 BACKGROUND

• Eastburn E, Hernandez MA, Boretsky K. Technical success of the ultrasound-guided supra-inguinal fascia iliaca compartment block in older children and adolescents for hip arthroscopy. Paediatr Anaesth. 2017 Nov;27(11):1120-1124. doi: 10.1111/pan.13227.

  PMID: 29030933 BACKGROUND

• Alves WM Jr, Migon EZ, Zabeu JL. PAIN FOLLOWING TOTAL KNEE ARTHROPLASTY - A SYSTEMATIC APPROACH. Rev Bras Ortop. 2015 Dec 12;45(5):384-91. doi: 10.1016/S2255-4971(15)30424-9. eCollection 2010 Sep-Oct.

  PMID: 27022583 BACKGROUND

Related Links

• Related Info

MeSH Terms

Conditions

Hip Fractures; Agnosia

Condition Hierarchy (Ancestors)

Femoral Fractures; Fractures, Bone; Wounds and Injuries; Hip Injuries; Leg Injuries; Perceptual Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 19, 2026
• First Posted: June 10, 2026
• Study Start: May 15, 2025
• Primary Completion: January 31, 2026
• Study Completion: January 31, 2026
• Last Updated: June 10, 2026

Record last verified: 2026-06

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)